Results 31 to 40 of about 11,707,023 (237)

Post-Acute Sequelae of COVID-19 and Polypharmacy: If You Think There’s Too Much Polypharmacy Now, Just Wait

open access: yesThe University of Louisville Journal of Respiratory Infections, 2021
The intersection of increased chronic disease burden worldwide with the COVID-19 pandemic was called the “perfect storm”. This article discusses yet another perfect storm: Post COVID-19 (acute and non-acute) syndrome, high chronic disease burdens ...
Demetra Antimisiaris
doaj   +1 more source

Cardiac Complications of COVID-19 in Low-Risk Patients

open access: yesViruses, 2022
The coronavirus disease 2019 (COVID-19) pandemic has resulted in over 6 million deaths and significant morbidity across the globe. Alongside common respiratory symptoms, COVID-19 is associated with a variety of cardiovascular complications in the acute ...
Akash Srinivasan   +3 more
doaj   +1 more source

Biomarkers of pulmonary fibrosis in COVID-19 and postcovid syndrome

open access: yesЛечащий Врач, 2022
COVID-19 can occur in the form of an acute respiratory viral infection of a mild course, or in a severe form. Both effective treatments for the acute phase of the disease and the clinical and functional long-term consequences of COVID-19, which include ...
M. K. Kurbanaliev   +5 more
doaj   +1 more source

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19. [PDF]

open access: yes, 2022
Introduction Post-COVID-19 syndrome affects approximately 10-25% of people suffering from COVID-19 infection, irrespective of initial COVID-19 severity.
Kamber, Nicole   +14 more
core   +2 more sources

A cross–sectional study of post–COVID syndrome at a tertiary care center in Turkey

open access: yesAsian Pacific Journal of Tropical Medicine, 2022
Objective: To investigate long-term symptoms after acute COVID-19, the link between symptoms and respiratory function, radiological changes in the post-COVID period, and risk factors for post-COVID syndrome.
Efraim Guzel   +5 more
doaj   +1 more source

COVID-19 delirium and encephalopathy: Pathophysiology assumed in the first 3 years of the ongoing pandemic

open access: yesBrain Disorders, 2023
Background: The coronavirus disease (COVID-19) continues to spread worldwide. It has a high rate of delirium, even in young patients without comorbidities.
Kyohei Otani   +2 more
doaj   +1 more source

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury [PDF]

open access: yes, 2023
A proportion of patients infected with severe acute respiratory syndrome coronavirus 2 experience a range of neuropsychiatric symptoms months after infection, including cognitive deficits, depression and anxiety. The mechanisms underpinning such symptoms
Mummery, Catherine J   +82 more
core   +1 more source

COVID-19 atypical Parsonage-Turner syndrome: a case report

open access: yes, 2022
BACKGROUND: Neurological manifestations of Sars-CoV-2 infection have been described since March 2020 and include both central and peripheral nervous system manifestations.
Landi F.   +5 more
core   +1 more source

SARS-CoV-2, COVID-19 and Parkinson’s Disease—Many Issues Need to Be Clarified—A Critical Review

open access: yesBrain Sciences, 2022
Neurological manifestations during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic are of interest, regarding acute treatment and the so-called post-COVID-19 syndrome.
Tsepo Goerttler   +5 more
doaj   +1 more source

Clinical outcomes and lung mechanics characteristics between COVID-19 and non-COVID-19-associated acute respiratory distress syndrome: a propensity score analysis of two major randomized trials

open access: yes, 2022
Objective: To compare the lung mechanics and outcomes between COVID-19-associated acute respiratory distress syndrome and non-COVID-19-associated acute respiratory distress syndrome.
Luciano César Pontes de Azevedo (4769637)   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy